Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Biological source:
bovine fetus
Origin:
Australia origin
Sterility:
γ-irradiated, sterile-filtered
Shipped in:
dry ice
biological source
bovine fetus
Quality Level
sterility
γ-irradiated, sterile-filtered
product line
FBS Premier
composition
Hemoglobin, ≤25 mg/dL
origin
Australia origin
technique(s)
cell culture | mammalian: suitable
impurities
≤10 EU/mL endotoxin
shipped in
dry ice
storage temp.
−20°C
Application
FBS sourced from Australia is used in a broad range of cell culture applications. FBS provides many non-defined growth promoting and survival enhancing factor to cells in culture. Australia carries the best possible rating in relation to Geographical Bovine Spongiform Encephalopathy (BSE) Risk (GBR) as designated by the Scientific Steering Committee on the Geographical Risk of Bovine Spongiform Encephalopathy. The classification for Australia is GBR Level I.
Preparation Note
Gamma irradiation by SER-TAIN™ process (25-35kGy).
Analysis Note
- Endotoxin and hemoglobin tested
- Tested for the presence of bacteria, virus, and mycoplasma
- Triple filtered with 0.1 micron membrane under aseptic conditions
Other Notes
(Formerly product number F3297)
Legal Information
SER-TAIN is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under Fetal Bovine Serum
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
SAFC Biosciences - The accomplished serum provider. In today's increasingly regulated world it is essential to have complete confidence in the origin of your serum. Australian-origin Fetal Bovine Serum (FBS) is recognized as the safest serum available in commercially viable volumes.
Annelies Jorritsma-Smit et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 143, 105096-105096 (2019-11-02)
Therapeutic vaccination is being explored as a treatment strategy for the treatment of patients with primary or metastatic tumours. We developed a vaccine targeted to Human papillomavirus (HPV)-induced tumours based on recombinant Semliki Forest virus (rSFV) encoding a fusion protein
Ruth M Risueño et al.
PloS one, 3(3), e1747-e1747 (2008-03-06)
How the T cell antigen receptor (TCR) discriminates between molecularly related peptide/Major Histocompatibility Complex (pMHC) ligands and converts this information into different possible signaling outcomes is still not understood. One current model proposes that strong pMHC ligands, but not weak
Li Zhou et al.
Genome biology, 9(7), R119-R119 (2008-07-31)
CD8+ NKT-like cells are naturally occurring but rare T cells that express both T cell and natural killer cell markers. These cells may play key roles in establishing tolerance to self-antigens; however, their mechanism of action and molecular profiles are